Medicine
Global

Medicine Experts

Henk Brulleman

Executive Director
pharmaceutical
BiomX
Israel

Biography

Henk Brulleman started his career at Royal Dutch Shell and rose to the position of deputy chief investment officer of their pension fund. He subsequently became a partner at Numeric Investors LLC, a Boston-based quantitative equity management firm, where he co-managed portfolios with a combined value of $3 billion and also handled client relations, marketing, and modeling. After retiring from Numeric, he built a portfolio of several equity and convertible debt stakes, predominantly in the field of life sciences, pharmaceuticals, and medical technology. He recently joined Wolkers & Co, a fiduciary asset manager providing multi-family office services, as a partner. Henk holds the equivalent of a M.Sc in Business Economics from the Free University in Amsterdam and is a CFA Charterholder.    

Research Interest

Pharmaceutical science 

Global Experts from Israel

Global Experts in Subject

Share This Profile